Pharmaceuticals News

Attached are copies of two filings with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the pledging...

Í viðhengi er tvær tilkynningar sem lagðar voru inn til birtingar hjá fjármálaeftirliti Lúxemborgar, Luxembourg Commission de Surveillance du Secteur Financier (CSSF) varðandi viðskipti stjórnenda og...

 Aggregated presentation by day and by market Purchases of own shares from June 22nd to June 26th 2026       Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the...

Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 22 juin au 26 juin 2026       Nom de l'émetteurCode identifiant de l'émetteur (code LEI)Jour...

TORONTO, ONTARIO, July 03, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”), today announced the previously announced consolidation (the...

SAN DIEGO, July 03, 2026 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a biopharmaceutical company committed to realizing the promise of precision medicines for the...

ORION CORPORATION PRESS RELEASE 3 JULY 2026 at 9.00 EEST         Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026         Orion will publish Half-Year...

ORION OYJ        LEHDISTÖTIEDOTE        3.7.2026 KLO 9.00         Orion julkaisee puolivuosikatsauksen 1–6/2026 ja järjestää verkkolähetyksen 17.7.2026 Orion julkaisee puolivuosikatsauksen...

MONTREAL and CHARLOTTE, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards,...

BOSTON, July 02, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, on July 1, 2026, the...